Major causes of morbidity and mortality in myeloproliferative neoplasms are represented by
arterial and venous complications, progression to myelofibrosis, and transformation to acute …

Thrombosis is a leading cause of morbidity and mortality in patients with Philadelphia
chromosome–negative myeloproliferative neoplasms (MPNs), particularly polycythemia vera …

Essentials• Cancer patients have a high rate of venous thrombosis (VT) but the underlying
mechanisms are unknown.• Tumor‐derived, tissue factor‐positive microvesicles in platelet …

Among the most common causes of death worldwide, ischemic heart disease (IHD) is
recognized to rank first. Even if atherosclerotic disease of the epicardial arteries is known as …

Thrombosis is a major cause of morbidity and mortality in cancer patients. The pathogenesis
of blood coagulation activation in oncological patients is complex and involves both clinical …

Thrombotic events are very frequent and represent the main cause of morbidity and mortality
in patients with Philadelphia chromosome–negative myeloproliferative neoplasms (MPNs) …

Philadelphia‐negative myeloproliferative neoplasms are considered to be acquired
thrombophilic states. Thromboses, both arterial and venous (not rarely in unusual sites), are …

Splanchnic vein thrombosis (SVT) is one of the most important complications of
myeloproliferative neoplasms (MPN). Although MPN are common causes of SVT, the …

Venous thromboembolism (VTE) is one of the three most common cardiovascular diseases
in the United States. It is also a leading cause of death among patients with cancer. Cancer …

Thrombosis, both in arterial and venous territories, is the major complication of
myeloproliferative neoplasms and is responsible for a high rate of morbidity and mortality …